Macquarie Group LTD Sorrento Therapeutics, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $4,123 - $7,865	-2,731 Reduced 68.76%	1,241 $6,000
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $4,365 - $10,252	-621 Reduced 13.52%	3,972 $33,000
Q2 2020 Aug 11, 2020	BUY	$1.73 - $6.76 $7,945 - $31,048	4,593 New	4,593 $29,000
Q3 2018 Nov 15, 2018	SELL	$4.22 - $7.5 $13,926 - $24,750	-3,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $7,600 - $12,800	1,600 Added 94.12%	3,300 $24,000
Q1 2018 May 11, 2018	BUY	$4.5 - $9.95 $7,650 - $16,915	1,700 New	1,700 $9,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.